Login

Anders Hinsby, CEO of Orphazyme 00:00:00

Share On Facebook Share On Twitter

Navigating the rare disease space: Insights from Orphazyme's CEO

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Terry Topping Unveils Kairos Minerals' Gold and Lithium Prospects in the Pilbara
00:10:00
HSBC Initiates Buy Ratings on Marriott and Booking Holdings Amid Consumer Spending Concerns
00:10:00
GreenRoc Mining CEO Dr. Stefan Bernstein Discusses Greenland’s Mining Potential and Production Roadmap | Dr. Stefan Bernstein, CEO, GreenRoc Mining PLC.
00:10:00
Real Estate Perspectives with Gonzalo de la Serna | Gonzalo de la Serna, CEO, Consultatio SA.
00:10:00
Interview with Chesapeake Gold Corp's Interim CEO John Paulos at the 1-2-1 Mining Investment New York Event.
00:10:00
Sandfire Resources: Expanding Copper Discoveries in Botswana's Kalahari Copper Belt
00:10:00
By staying ahead of technological trends and by staying connected, we can also continually optimise your technology and the service we provide you|Jonas Hasselberg,CEO,proact it group
00:10:00
Philippines' Energy Transition: A Call for National Collaboration | Eric Francia, CEO, Acen Corp.
00:10:00
Watch Mr. Sohel Sadat, Chairman of SHIN SHIN GROUP, discuss the significance and impact of the Bangladesh Denim Expo in promoting the denim industry.
00:10:00
Kuvera interviews Rahul Singh, Chief Investment Officer - Equities at Tata Asset Management, about Multi Cap Funds.|Gaurav Rastogi is the CEO of Kuvera
00:10:00
Navigating Financial Planning and Business Ownership: Insights from Hannah Moore, CFP®
00:10:00
XPON Technologies with Proactive at the ASX Small and Mid-Cap Conference | Matt Forman, CEO, XPON Technologies Group LtdXPN:ASX

© 2017 - Neuhu+